{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:28:10Z","timestamp":1789835290215,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.neuropharm.2005.01.009","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T12:34:10Z","timestamp":1111494850000},"page":"984-992","source":"Crossref","is-referenced-by-count":62,"title":["Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: Implications for treating Parkinson's disease?"],"prefix":"10.1016","volume":"48","author":[{"given":"Sen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2005.01.009_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/er.20.2.101","article-title":"Molecular biology of adenosine triphosphate-sensitive potassium channels","volume":"20","author":"Aguilar-Bryan","year":"1999","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(92)90513-4","article-title":"Behavioral effects of modulators of ATP-sensitive K+ channels in the rat dorsal pallidum","volume":"217","author":"Amalric","year":"1992","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.ne.11.030188.000525","article-title":"Adenosine 5\u2032-triphosphate-sensitive potassium channels","volume":"11","author":"Ashcroft","year":"1998","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson's disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(98)00956-1","article-title":"Distribution and phenotype of neurons containing the ATP sensitive potassium channel in rat brain","volume":"814","author":"Dunn-Meynell","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib10","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1073\/pnas.92.10.4666","article-title":"Essential role of adenosine, adenosine A1 receptors, and ATP sensitive K+ channels in cerebral ischemic preconditioning","volume":"92","author":"Heurteaux","year":"1995","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1212\/WNL.51.2.649","article-title":"Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease","volume":"51","author":"Horstink","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib12","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1046\/j.1471-4159.1996.66062562.x","article-title":"The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex","volume":"66","author":"Lee","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0028-3908(91)90061-F","article-title":"Psychopharmacological evidence for a role of the ATP-sensitive potassium channel in the substantia nigra of the rat","volume":"30","author":"Levesque","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09687680110047373","article-title":"Molecular physiology of neuronal KATP channels","volume":"18","author":"Liss","year":"2001","journal-title":"Molecular Membrane Biology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/emboj\/18.4.833","article-title":"Alternative sulfonylurea receptor expression defines metabolic sensitivity of KATP channels in dopaminergic midbrain neurons","volume":"18","author":"Liss","year":"1999","journal-title":"EMBO Journal"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00231786","article-title":"Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity","volume":"109","author":"Lorenc-Koci","year":"1996","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0306-4522(96)00407-1","article-title":"Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat","volume":"76","author":"Kaur","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","article-title":"NMDA antagonists potentiate antiparkinsonian actions of l-dopa in monoamine-depleted rats","volume":"28","author":"Klockgether","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/exnr.1996.0075","article-title":"Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease","volume":"139","author":"Maneuf","year":"1996","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-200320050-00006","article-title":"Glutamate receptors and Parkinson's disease","volume":"20","author":"Marino","year":"2003","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(90)90057-I","article-title":"Sulfonylureas binding sites associated with ATP-regulated Kq channels in the nervous system: autoradiographic analysis of their distribution and ontogenesis, and of their localization in mutant mice cerebellum","volume":"519","author":"Mourre","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1023\/A:1026620316090","article-title":"G proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals","volume":"25","author":"Neusch","year":"2000","journal-title":"Neurochemistry Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib34","unstructured":"Paxinos, G., Watson, C., 1997. The Rat Brain in Stereotaxic Coordinates. compact third ed. Academic Press, San Diego."},{"key":"10.1016\/j.neuropharm.2005.01.009_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3940(98)00458-3","article-title":"Opening of ATP-sensitive potassium channels by cromakalim confers tolerance against chemical ischemia in rat neuronal cultures","volume":"250","author":"Reshef","year":"1998","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jnr.10309","article-title":"Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease","volume":"69","author":"Tai","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(95)00730-X","article-title":"ATP-sensitive K+ channel openers block sulpiride-induced dopamine release in the rat striatum","volume":"297","author":"Tanaka","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib27","first-page":"240","article-title":"Pharmacological characteristics of the novel antihypertensive drug iptakalim hydrochloride and its molecular mechanisms","volume":"54","author":"Wang","year":"2002","journal-title":"Drug Development Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib28","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1523\/JNEUROSCI.15-04-03065.1995","article-title":"Putative pre- and postsynaptic ATP-sensitive potassium channels in the rat substantia nigra in vitro","volume":"15","author":"Watts","year":"1995","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib29","first-page":"127","article-title":"ATP-sensitive K(+) channels in the brain: sensors of hypoxic conditions","volume":"17","author":"Yamada","year":"2002","journal-title":"News in Physiological Sciences"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/ajpcell.1998.274.1.C25","article-title":"ATP sensitive potassium channel in pancreatic, cardiac, and vascular cells","volume":"274","author":"Yokoshiki","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(94)91774-4","article-title":"Distinct sites of dopaminergic and glutamatergic regulation of haloperidol induced catalepsy within the rat caudate\u2013putamen","volume":"639","author":"Yoshida","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1254\/jjp.79.59","article-title":"ATP-sensitive potassium channels regulate in vivo dopamine release in rat brain","volume":"79","author":"Zhu","year":"1999","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.009_bib33","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1073\/pnas.212315199","article-title":"Kir6.2 is required for adaptation to stress","volume":"99","author":"Zingman","year":"2002","journal-title":"Proceedings of the National Academy of Sciences, USA"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:39:51Z","timestamp":1549327191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0028390805000432"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.01.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}